Topcare Clearlax Powder, For Solution
Product Images NDC 76162-119

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Topcare Clearlax (NDC 76162-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Topco Associates Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clearlax Front Label (Image 01)

Clearlax Front Label (Image 01)
Topcare ClearLax polyethylene glycol 3350 powder for solution in oral dosage form. The label highlights that it is grit-free, sugar-free, and dye-free, with orange-flavored powder. The net weight is 8.3 oz (238 g), providing 14 once-daily doses. The label also includes a comparison to Miralax active ingredient and states it relieves occasional constipation and softens stool.*
FDA Label Image

Clearlax Back Label (Image 02)

Clearlax Back Label (Image 02)
Drug Facts for Topcare ClearLax Polyethylene Glycol 3350, 17 g powder for solution. The panel details active ingredient, uses, warnings, directions, inactive ingredients, and storage instructions. It includes allergy alerts, dosage directions, and customer contact information. The label advises consulting a doctor before use in certain conditions and highlights that the product is gluten-free with tamper-evident packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.